Neurogene (NGNE) Receivables (2013 - 2015)

Neurogene posted quarterly Receivables of $32000.0 for Q4 2015, down 50.77% year-on-year from $65000.0 in Q4 2014, and up 68.42% on a QoQ basis from $19000.0 in Q3 2015.

Neurogene (NGNE) has 3 years of Receivables data on file, last reported at $32000.0 in Q4 2015.

  • For the quarter ending Q4 2015, Receivables fell 50.77% year-over-year to $32000.0; the trailing twelve-month figure through Dec 2015 stood at $32000.0 (down 50.77% YoY), and the FY2015 full-year result was $32000.0, down 50.77% from the prior year.
  • Receivables for Q4 2015 stood at $32000.0, up from $19000.0 in the prior quarter.
  • Across five years, Receivables topped out at $76243.0 in Q3 2014 and bottomed at $19000.0 in Q3 2015.
  • The 3-year median for Receivables is $57000.0 (2015), against an average of $49898.9.
  • The widest annual swing landed in 2014, when Receivables surged 132.59%; it then slumped 75.08% in 2015.
  • A 3-year view of Receivables shows it stood at $27946.0 in 2013, then jumped by 132.59% to $65000.0 in 2014, then plunged by 50.77% to $32000.0 in 2015.
  • The last three Receivables figures came in at $32000.0 (Q4 2015), $19000.0 (Q3 2015), and $72000.0 (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 13.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 4.15 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2.00 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 5.73 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 883.96 Mn
10 Neurogene 632.14 Mn 632.14 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 32,000.00
Sep 30, 2015 19,000.00
Jun 30, 2015 72,000.00
Mar 31, 2015 57,000.00
Dec 31, 2014 65,000.00
Sep 30, 2014 76,243.00
Jun 30, 2014 33,375.00
Mar 31, 2014 66,526.00
Dec 31, 2013 27,946.00